Evidence map›Paper›PMID 12682124›Full record

ArticleJournal of clinical microbiology2003

Prospective value of PCR amplification and sequencing for diagnosis and typing of old world Leishmania infections in an area of nonendemicity.

Jean-Pierre Gangneux, Jean Menotti, Frédéric Lorenzo, Claudine Sarfati, Hélène Blanche, Hung Bui, Francine Pratlong, Yves-Jean-François Garin, Francis Derouin

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Eyelid nodule with persistent growth.JAAD case reports · 2025
    Article
  3. Isolation and Molecular Identification ofIranian journal of public health · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean-Pierre GangneuxLaboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire Lariboisière-Saint-Louis, 75010 Paris, France. jean-pierre.gangneux@univ-rennes1.fr
Jean Menotti
Frédéric Lorenzo
Claudine Sarfati
Hélène Blanche
Hung Bui
Francine Pratlong
Yves-Jean-François Garin
Francis Derouin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed the prospective value of PCR amplification of a repetitive sequence from Leishmania nuclear DNA and sequencing for the diagnosis and typing of Old World Leishmania infection in an area of nonendemicity. During this 42-month study, 29 of 168 consecutive samples were examined and classified as positive for Leishmania by direct examination and/or in vitro culture. This molecular approach showed excellent sensitivity (97%) and specificity (100%) compared to direct examination (86 and 100%, respectively) and in vitro culture (72 and 100%, respectively). Isoenzymatic and molecular typing allowed similar identification for 12 samples. Besides, PCR and subsequent sequencing of DNA products permitted the species identification of 14 samples for which parasite culture remained negative or did not allow isoenzymatic characterization, indicating the complementarity of parasitological and molecular tools.

Indexed as

Sequence Analysis, DNAAnimalsBase SequenceCulture MediaDNA, ProtozoanHumansIsoenzymesLeishmaniaLeishmaniasis, CutaneousLeishmaniasis, VisceralMolecular Sequence DataPolymerase Chain ReactionPredictive Value of TestsSensitivity and SpecificitySpecies SpecificityCulture MediaDNA, ProtozoanIsoenzymes

Identifiers

PMID12682124
PMCPMC153908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.